Oct 14, 2026 · 1h 10m
AI pushes healthcare toward a new operating model
Thrive Capital's Bet on Neuralink, OpenAI & the Future of Medicine
The episode examines whether AI can improve care and drug development while confronting the scale, cost, and unequal outcomes of American healthcare.
- 1AI could reduce drug-development timelines and biological risk by connecting advanced research with industry expertise.
- 2Healthcare’s biggest opportunities may combine technology with measurable improvements in quality of life and clinical outcomes.
- 3AI is entering healthcare workflows and information services before the system has resolved its economic and access disparities.
Don't miss
Ayogu argues that OpenAI may already function as one of the world’s largest healthcare information providers because of the volume of health questions directed to ChatGPT.
The brief
Physician and Thrive Capital healthcare investor Nworah Ayogu argues that AI, biology, and healthcare are converging as the U.S. spends heavily without consistent gains in life expectancy.
The investment thesis favors companies that can operate in both technology and their target industry, from Isomorphic Labs’ drug-discovery work to Neuralink’s effort to restore capabilities for people with paralysis and ALS.
Ayogu frames healthcare innovation around quality of life as well as longevity, using Neuralink and Fōrward’s AI-enabled hearing aid to illustrate how technology can address neglected, widespread needs.
The conversation then shifts from products to systems: AI is changing front-office, back-office, and clinical workflows, while OpenAI’s reach in health information raises questions about scale and responsibility.
Cadence represents the measurable-outcomes case, combining remote monitoring, AI, and clinical support for high-risk patients while targeting better blood pressure and diabetes control and Medicare savings.
The episode closes on a larger wager: AI could create new healthcare leaders, but its promise will be tested against costs, policy, labor, and unequal outcomes.